
|Articles|April 18, 2019
The Era of PARP Inhibition in Cancer Management - Patient Selection and Deciding When to Use in Treatment
https://www.pharmacytimes.org/on-demand/the-era-of-parp-inhibition-in-cancer-management-patient-selection-and-deciding-when-to-use-in-treatment-enduring
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
2
AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans
3
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
4
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
5




